Tag Archives: HighRisk

Blog

Sufferers with high-risk giant B-cell lymphoma lived longer with axi-cel

Posted on by asifakberd41@gmail.com
06
Jun

Sufferers with early relapsed or refractory giant B-cell lymphoma had considerably improved general survival when handled with the chimeric antigen receptor (CAR) T cell remedy axicabtagene ciloleucel (axi-cel) when in comparison with the present standard-of-care chemoimmunotherapy, in line with outcomes of the Part III ZUMA-7 trial reported by researchers from The College of Texas MD […]

Continue reading →
Blog

WHO Shares New COVID-19 Vaccination Steerage As Excessive-Danger Individuals Wait For Second Bivalent Boosters

Posted on by asifakberd41@gmail.com
29
Mar

The World Well being Group (WHO) introduced new vaccination steerage because the world continues to grapple with Omicron and its subvariants. In a information launch Tuesday, the WHO mentioned its Strategic Advisory Group of Consultants on Immunization (SAGE) revised the roadmap for prioritizing using the vaccines to mirror the impression of omicron alongside the immunity […]

Continue reading →